Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

In 2021, 529 million people were living with diabetes worldwide, and an estimated 1·31 billion individuals are projected to have diabetes (>90% type 2 diabetes) by 2050.1 The diabetes epidemic is ...

Insulin pumps are wearable devices that people with diabetes use to deliver insulin. They are connected to a spot on your body and continuously give insulin for 2 to 4 days. An insulin pump is a ...

With type 1 diabetes, the pancreas does not produce insulin because the body’s immune system attacks the cells that make it. Therefore, a person with type 1 diabetes needs to take additional ...

1 Department of Pharmacy, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China 2 Department of Pharmacy, The First Hospital of Changsha, ...

It is typically administered twice a day, as opposed to newer long-lasting insulins, degludec (Tresiba) and glargine (Lantus), which may only require one daily dose. NPH insulin also necessitates ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out Penfill cartridges. This decision follows concerns about the discontinuation ...

Mumbai: Amidst the ongoing news of conventional insulin market disruption and growing concern over potential shortages triggered by Novo Nordisk's decision to withdraw key human insulin products in ...

Medtronic is seeking Food and Drug Administration clearance for an interoperable version of its latest insulin pump, an important step in the manufacturer’s collaboration with diabetes technology ...

Right: Medtronic’s MiniMed 780G. [Image courtesy of the companies] Medtronic (NYSE:MDT) announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...

The transformation of one of my 35-year-old patients shows how it is possible to not only eliminate insulin dependence but live drug-free. Provided you start early and follow your discipline strictly ...

Thirty-seven-year-old Nupur Lalvani, who has been living with Type 1 diabetes since the age of eight, was dependent on insulin pens and had of late been a regular user of Novo Nordisk’s largest ...